FairJourney Biologics has announced its successful #ANTIBODY SERIES #conference will return in 2022, with Ton Logtenberg as Chairman. This year’s event attracted over 800 online participants and 150 in-person attendees. Read more: https://t.co/DpkcplYkCK @IontasLtd
GammaDelta Therapeutics announced that the first patients have been dosed in its multi-centre US Phase I #clinicaltrial to evaluate GDX012, a novel gamma-delta T cell therapy for the treatment of acute myeloid #leukaemia. Read here: https://t.co/3NUUFdTPnh
Only 1 week until @BioForwardUK!
Join us LIVE in-person on 23 Sep at The King's Centre in #Oxford, along with #RandD industry leaders to discuss #sustainable #commercial success. You can still register online: https://t.co/BYT2dPmKmA
#BioForward @OBN_UK
. @OwlstoneMedical today announced the appointment of Mark Capone, former President & CEO of Myriad Genetics, to its Board as an independent non-executive director, to support the clinical advancement of its Breath Biopsy® platform. Read here: https://t.co/YllwiZhFAf
.@Optibrium today announced the release of StarDrop 7.1, its comprehensive software platform for small #molecule design, optimisation and data analysis.
Read more: https://t.co/VYbypZNqmM
#drugdiscovery #biotechnology #ai
We're pleased to be media partner at @OBN_UK's upcoming live event, @BioForwardUK. Join us and #RandD experts in-person on 23 Sep at The King's Centre in #Oxford to discuss #sustainable #commercial success.
Register here: https://t.co/BYT2dPmKmA
#BioForward
